Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2025-12-25 @ 1:14 AM
NCT ID:
NCT07150793
Eligibility Criteria:
Patients who met all the below inclusion criteria and none of the exclusion criteria were included in the study.
Inclusion criteria:
* Patients who had at least one TKI prescription during the selection period,
* a confirmed diagnosis of chronic phase CML recorded before or at the index date,
* were aged 15 years or older at the index date, and
* had at least 12-months continuous pre-index period.
Exclusion criteria:
* Patients who had at least one TKI prescription in the 12 months preceding the index date (washout period to catch the 1st line of treatment \[LoT\]),
* a confirmed diagnosis of CML blast crisis or accelerated phase recorded prior to, at, or within 6 months after the index date,
* a confirmed diagnosis of acute myeloid leukemia (AML) or acute lymphoblastic leukemia (ALL) within 6 months after the index date,
* a medical record of chemotherapy (not including hydroxyurea) within 6 months after the index date,
* a stem cell transplant procedure recorded during the pre-index period.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
15 Years
Study:
NCT07150793
Study Brief:
Protocol Section:
NCT07150793